Results
73,160 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 12 | Rubin JonathanSVP, Chief Medical Officer |  SUPNSUPERNUS PHARMACEUTICALS, INC.Other acquisition or disposition | J | — 3,500 sh |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 12 | Rubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,500 sh |
| Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Runnette Deirdre L.Chief Legal Officer |  BMBLBumble Inc.Tax withholding | F | $238K 39.9K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Gemayel GeorgesDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 7,296 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 7,905 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 2,989 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Ludwig Jeffrey G.Director, President & CEO |  MSBIMidland States Bancorp, Inc.Tax withholding | F | $93K 2,814 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 250.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 300.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 14.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Bhatt Padmanabh P.Sr. VP of IP, CSO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 2,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 400.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 6,293 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Gemayel GeorgesDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 2,989 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Burchianti RalphDirector |  CBFVCB Financial Services, Inc.Option exercise | M | $74K 2,810 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 17.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Rubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 20.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Barlow CarroleeDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 2,989 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Gemayel GeorgesDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 8,613 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Watkins PhilipEVP, Head of Corp Devel & IR |  CUBICustomers Bancorp, Inc.Option exercise | M | $57K 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Rubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 25.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 958.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 4,977 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 8,252 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Rubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 4,250 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 331.7K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,750 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 100.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 19.5K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 25.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,375 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 40.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Clark Joseph GatesSVP and Pres, Optimized LED |  PENGPenguin Solutions, Inc.Open-market sale · 10b5-1 plan | SELL | $75K 1,573 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Maetzold Derek JDirector, Pres. & Chief Exec. Officer |  CSTLCASTLE BIOSCIENCES INCOpen-market sale · 10b5-1 plan | SELL | $38K 1,025 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Hall John TDirector, Chief Executive Officer |  INTAIntapp, Inc.Open-market sale · 10b5-1 plan | SELL | $50K 1,100 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Hasson Heather L.Director, Executive Chairman, 10% Owner |  FIGSFIGS, Inc.Tax withholding | F | $642K 30.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Tsao DavidDirector, Chief Technology Officer |  BLLNBillionToOne, Inc.Open-market sale · 10b5-1 plan | SELL | $98K 917 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | van Houte HansChief Financial Officer |  NRIXNurix Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $24K 1,469 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 11 | Bernstein David CChief Accounting Officer |  ABNBAirbnb, Inc.Open-market sale · 10b5-1 plan | SELL | $294K 1,756 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Oughtred SarahChief Financial Officer | FIGSFIGS, Inc. Tax withholding | F | $468K 22.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Zuraitis MaritaDirector, President & CEO |  HMNHORACE MANN EDUCATORS CORP /DE/Open-market sale · 10b5-1 plan | SELL | $354K 7,500 sh | Nov 4, 2026 traded Nov 2, 2026 |